Fed. Circ. Upholds Validity Of Sanofi's Plavix Patent
In an upset for Canadian generic-drug maker Apotex Inc., a federal appeals court has upheld a lower court's ruling that a patent covering the active ingredient in Sanofi-Aventis' blockbuster blood-thinner Plavix...To view the full article, register now.
Already a subscriber? Click here to view full article